Table 4.

Inhibition of lung metastasis of B16 melanoma cells with peroral administration of EGCG

	Hematogenous metastasis with B16-F10 cells		Lymphogenous metastasis with B16-BL6 cells
Groups	Average number of lung nodules	% of inhibition	Average number of lung nodules	% of inhibition
Control	>150*		25*
0.05% EGCG	107*	>29%	7*	72%
0.1% EGCG	76*	>50%	10*	60%

^*P < 0.01